SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-02-004129
Filing Date
2002-08-14
Accepted
2002-08-14 16:05:51
Documents
3
Period of Report
2002-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q j4280_10q.htm 10-Q 410411
3 EX-10 j4280_ex10.htm EX-10 258947
4 EX-99.1 j4280_ex99d1.htm EX-99.1 9142
  Complete submission text file 0001104659-02-004129.txt   680094
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21481 | Film No.: 02736557
SIC: 2836 Biological Products, (No Diagnostic Substances)